The disappearance of onchocerciasis from the Itwara focus, western Uganda after elimination of the vector Simulium neavei and 19 years of annual ivermectin treatments

Acta Tropica

Volumn 126, Issue 3, 2013, Pages 218-221

  Lakwo, T L ^a   Garms, R ^b   Rubaale, T ^c   Katabarwa, M ^d   Walsh, F ^e   Habomugisha, P ^f   Oguttu, D ^a   Unnasch, T ^g   Namanya, H ^a   Tukesiga, E ^h   Katamanywa, J ⁱ   Bamuhiiga, J ^j   Byamukama, E ^f   Agunyo, S ^f   Richards, F ^d  

^a MINISTRY OF HEALTH   (Uganda)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c Community Basic Health Services ^*  (Uganda)

^d CARTER CENTER   (United States)

^e Lytham St Annes   (United Kingdom)

^f Uganda Office   (Uganda)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

^h Kabarole District Local Government   (Uganda)

ⁱ Kyenjojo District Local Government   (Uganda)

^j Fort Portal Regional Referral Hospital   (Uganda)

more..

Author keywords

Disease elimination; Itwara focus; Ivermectin; Onchocerciasis; Uganda; Vector elimination

Indexed keywords

IMMUNOGLOBULIN G4; IVERMECTIN; OV 16 ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN; CERTIFICATION; CHILD HEALTH; DISEASE CONTROL; DISEASE TREATMENT; DISEASE VECTOR; GUIDELINE; ONCHOCERCIASIS; WORLD HEALTH ORGANIZATION;

ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FOREST; HUMAN; HUMAN TISSUE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MICROFILARIA; MICROSCOPY; NONHUMAN; ONCHOCERCIASIS; PARASITE EXAMINATION; PARASITE VECTOR; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SIMULIUM; SIMULIUM NEAVEI; SKIN BIOPSY; TREND STUDY; UGANDA; VECTOR CONTROL;

UGANDA;

SIMULIUM NEAVEI;

EID: 84875294442     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2013.02.016     Document Type: Article

References (17)

1. Cupp E. Guide to detecting a potential recrudescence of onchocerciasis during the post treatment surveillance period: the American paradigm. Res. Rep. Trop. Med. 2012, 3:21-33.
2. Fischer P., Kipp W., Bamuhiiga J., Binta-Kahwa J., Kiefer A., Büttner D.W. Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda. Trop. Med. Parasitol. 1993, 44:311-321.
3. Garms R., Lakwo T.L., Ndyomugyenyi R., Kipp W., Rubaale T., Tukesiga E., Katamanywa J., Post R.J., Amazigo U.V. The elimination of the vector Simulium neavei from the Itwara onchocerciasis focus in Uganda by ground larviciding. Acta Trop. 2009, 111:203-210.
4. Katabarwa M., Onapa A.W., Nakileza B. Rapid epidemiological mapping of onchocerciasis in areas of Uganda where Simulium neavei is the vector. East Afr. Med. J. 1999, 76:440-446.
5. Katabarwa M.N., Walsh F., Habomugisha P., Lakwo T.L., Agunyo S., Oguttu D.W., Unnasch T.R., Unoba D., Byamukama E., Tukesiga E., Ndyomugyenyi R., Richards F.O. Transmission of onchocerciasis in Wadelai focus of northwestern Uganda has been interrupted and the disease eliminated. J. Parasitol. Res. 2012, [Epub 2012, Aug 26].
6. Lindblade K.A., Arana B., Zea-Flores G., Rizzo N., Porter C.H., Dominguez A., Cruz-Ortiz N., Unnasch T.R., Punkosdy G.A., Richards J., Sauerbrey M., Castro J., Catú E., Oliva O., Richards F.O. Elimination of Onchocerca volvulus transmission in the Santa Rosa focus of Guatemala. Am. Jour. Trop. Med. Hyg. 2007, 77:334-341.
7. Lobos E., Weiss N., Karam M., Taylor H.R., Ottesen E.A., Nutman T.B. An immunogenic Onchocerca volvulus antig a specific early marker of infection. Science 1991, 251:1603-1605.
8. Ndyomugyenyi R., Tukesiga E., Buttner E.W., Garms R. The impact of ivermectin treatment alone and when in parallel with S. neavei vector elimination on onchocerciasis in Uganda. Trop. Med. Int. Health 2004, 9:882-886.
9. Ndyomugyenyi R., Lakwo T., Habomugisha P., Male B. Progress towards the elimination of onchocerciasis as a public health problem in Uganda: opportunities, challenges and way forward. Ann. Trop. Med. Parasit. 2007, 101:323-333.
10. Plaisier A.P., Alley E.S., van Oortmarssen G.J., Boatin B.A., Habbema J.D.F. Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in West Africa. Bull. World Health Organ. 1997, 75(3):237-245.
11. Roberts J.M.D., Neumann E., Göckel C.W., Highton R.B. Onchocerciasis in Kenya, 9, 11 and 18 years after elimination of the vector. Bull. World Health Organ. 1967, 37:195-212.
12. Toe L., Boatin B.A., Adjami A., Back C., Meriwether A., Unnasch T.R. Detection of Onchocerca volvulus infection by O-150 polymerase chain reaction analysis of skin scratches. J. Infect. Dis. 1998, 178:282-285.
13. Unnasch T.R., Meredith S.E.O. The use of degenerate primers in conjunction with strain and species oligonucleotide to classify Onchocerca volvulus. Species diagnostic protocols: PCR and other nucleic acid methods 1996, vol. 50:293-303. Humana Press, Totowa, NJ.
14. World Health Organization, 1995. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. Technical Report Series 852, 104 pp. Switzerland, Geneva.
15. World Health Organization, 1996. Community Directed Treatment with Ivermectin. A report of a Multi-country Study. Document TDR/AFRO/RP 96.1, Geneva, Switzerland.
16. World Health Organization, 2001. Certification of elimination of human onchocerciasis: criteria and procedures. Document WHO/CDS/CPE/CEE/2001.18a, 23pp. Geneva, Switzerland.
17. MOH (2012). Guidelines for Certification of Onchocerciasis Elimination in Uganda. June 2012.